title: Gene expression meta-analysis identifies VDAC1 as a predictor of poor outcome in early stage non-small cell lung cancer.
abstract: BACKGROUND
  The bioenergetic status of non-small cell lung cancer correlates with tumour aggressiveness. The voltage dependent anion channel type 1 (VDAC1) is a component of the mitochondrial permeability transition pore, regulates mitochondrial ATP/ADP exchange suggesting that its over-expression could be associated with energy dependent processes including increased proliferation and invasiveness. To test this hypothesis, we conducted an in vivo gene-expression meta-analysis of surgically resected non-small cell lung cancer (NSCLC) using 602 individual expression profiles, to examine the impact of VDAC1 on survival.
  
  
  RESULTS
  High VDAC1 expression was associated with shorter overall survival with hazard ratio (HR) = 0.6639 (95% confidence interval (CI) 0.4528 to 0.9721), p = 0.035352 corresponding to 52 versus 101 months. VDAC1 predicted shorter time to recurrence and was shown to be an independent prognostic factor compared with histology, gender, age, nodal stage and tumour stage in a Cox multivariate analysis. Supervised analysis of all the datasets identified a 6-gene signature comprising HNRNPC, HSPA4, HSPA9, UBE2D2, CSNK1A1 and G3BP1 with overlapping functions involving regulation of protein turnover, RAS-RAF-MEK pathway and transcription. VDAC1 predicted survival in breast cancer and myeloma and an unsupervised analysis revealed enrichment of the VDAC1 signature in specific subsets.
  
  
  CONCLUSIONS
  In summary, gene expression analysis identifies VDAC1 gene expression as a predictor of poor outcome in NSCLC and other cancers and is associated with dysregulation of a conserved set of biological pathways, which may be causally associated with aggressive tumour behaviour.
authors.affiliation: Centre for Biomedical Informatics, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom. c.grills@qub.ac.uk
authors.forename: Claire
authors.initials: C
authors.lastname: Grills
authors.forename: Puthen V
authors.initials: PV
authors.lastname: Jithesh
authors.forename: Jaine
authors.initials: J
authors.lastname: Blayney
authors.forename: Shu-Dong
authors.initials: SD
authors.lastname: Zhang
authors.forename: Dean A
authors.initials: DA
authors.lastname: Fennell
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics / Q000473:pathology; D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics / Q000473:pathology*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics / Q000473:pathology*; D009101:Multiple Myeloma / Q000235:genetics / Q000473:pathology; D011237:Predictive Value of Tests; D011379:Prognosis; D050995:Voltage-Dependent Anion Channel 1 / Q000032:analysis*
chemical_list: C494762:VDAC1 protein, human; D050995:Voltage-Dependent Anion Channel 1